Lexeo Therapeutics, Inc Common Stock
Price & Volume
Stats
See moreOpen | $7.99 |
Previous Close | $8.03 |
Day Range | $7.92-$8.33 |
52W Range | $1.45-$11.29 |
Market Cap | $450.3M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$73.6M |
Diluted EPS | -$3.21 |
News
See moreYahoo Finance • 3 days ago
Lexeo climbs after regulatory update on Friedreich ataxia drug
Yahoo Finance • 3 days ago
Lexeo Therapeutics Announces Progress in FDA Discussions for Accelerated Approval Pathway and Positive Interim Clinical Data for LX2006 in Friedreich Ataxia Cardiomyopathy
Yahoo Finance • 2 months ago
Lexeo Therapeutics stock price target lowered to $9 at H.C. Wainwright
Yahoo Finance • 2 months ago
Lexeo Therapeutics Reports Second Quarter 2025 Financial Results and Operational Highlights
About
CEO | Mr. R. Nolan Townsend |
CFO | Mr. Louis Tamayo |
Address | 345 Park Avenue South, New York, NY, United States, 10010 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 61 |
